Living with moderate-to-severe plaque psoriasis often feels like a constant battle between your skin and your immune system. For years, the gold standard for advanced treatment was restricted to costly biologics or broad immunosuppressants. However, the introduction of Deucravacitinib has changed the landscape, and with the availability of Cravacin 6 mg Tablet, this life-changing therapy is now more accessible than ever.
As a high-quality, cost-effective generic version of the innovator drug Sotyktu™, Cravacin offers a strategic solution for patients and healthcare providers seeking reliable results without the premium price tag.
What is Cravacin (Deucravacitinib)?
Cravacin is an oral, selective medication specifically indicated for adults with plaque psoriasis. It belongs to a cutting-edge class of drugs known as TYK2 inhibitors. Unlike older treatments that might require painful injections, Cravacin is a simple, once-daily pill that works from within to manage skin inflammation.
Key Facts:
-
Active Ingredient: Deucravacitinib (6 mg)
-
Form: Film-coated tablet
-
Indication: Moderate-to-severe plaque psoriasis
-
Manufacturer: Everest Pharmaceuticals Ltd.
Why Cravacin 6 mg Tablet is the “Best Price” Solution
The primary barrier to advanced psoriasis treatment has traditionally been cost. In many regions, the innovator brand can cost upwards of $1,600 to $6,000 per month.
The Cravacin 6 mg Tablet disrupts this model by offering:
-
Massive Cost Savings: As a generic manufactured in Bangladesh—a global hub for affordable, high-quality pharmaceuticals—Cravacin is available at a fraction of the cost of the brand-name version.
-
Identical Efficacy: It contains the same active ingredient and follows the same biological pathway, ensuring patients receive the same clinical benefits for skin clearance.
-
Sustainable Long-Term Care: Psoriasis is a chronic condition. Lowering the monthly cost makes long-term adherence possible, preventing flares and maintaining clear skin for years.
Global Supply and Accessibility
Everest Pharmaceuticals Ltd. has established a robust supply chain to ensure that Cravacin 6 mg Tablet reaches patients worldwide. Whether you are a distributor, a healthcare provider, or a patient in a region with limited access to expensive biologics, Cravacin is designed for global reach.
-
World-Class Manufacturing: Produced in GMP-compliant facilities that meet international regulatory benchmarks.
-
Export-Ready: Everest Pharmaceuticals specializes in international logistics, navigating the complexities of market registration and distribution to bring this TYK2 inhibitor to the global market.
-
Vertical Integration: By managing the manufacturing process from start to finish, the company ensures batch-to-batch consistency and long-term supply stability.
How It Works: The TYK2 Advantage
The effectiveness of the Cravacin 6 mg Tablet lies in its precision. In psoriasis, the immune system overproduces signals like Interleukin-23 (IL-23) and Type 1 Interferons, which cause skin cells to grow too fast and form plaques.
Cravacin targets an enzyme called Tyrosine Kinase 2 (TYK2). By blocking this specific enzyme, it shuts down the inflammatory “highway” without affecting other kinases (like JAK1, 2, or 3) that are essential for other body functions. This high level of selectivity is why Cravacin is often better tolerated than older systemic medications.
[Image showing the JAK-STAT signaling pathway and TYK2 inhibition]
Dosage, Administration, and Safety
For the best results, patients should adhere to the following guidelines:
-
Daily Dose: One Cravacin 6 mg Tablet daily.
-
Flexibility: Can be taken with or without food.
-
Method: Swallow the tablet whole; do not crush, cut, or chew.
Safety Information
Before starting Cravacin, patients should be evaluated for latent infections, particularly Tuberculosis (TB). Common side effects may include upper respiratory tract infections, cold sores, or acne. It is not recommended for patients with severe liver impairment (Child-Pugh C).
Compare: Cravacin vs. Innovator (Sotyktu™)
| Feature | Innovator (Sotyktu™) | Cravacin 6 mg Tablet |
| Active Ingredient | Deucravacitinib 6 mg | Deucravacitinib 6 mg |
| Route | Oral (Once Daily) | Oral (Once Daily) |
| Mechanism | Selective TYK2 Inhibitor | Selective TYK2 Inhibitor |
| Affordability | High (Premium Pricing) | Excellent (Generic Pricing) |
| Global Access | Limited by Insurance/Cost | Broad (Global Export) |
Secure Your Supply of Cravacin Today
The era of choosing between your finances and your health is over. With Cravacin 6 mg Tablet, you get an FDA-standard generic that delivers the latest in autoimmune science at a price that makes sense.
